欢迎来到天天文库
浏览记录
ID:55058529
大小:204.01 KB
页数:2页
时间:2020-05-08
《乙肝疫苗联合免疫球蛋白在阻断乙肝母婴传播中的临床疗效观察-论文.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、团匣曩强同2014年6月第12卷第16期·论著·77乙肝疫苗联合免疫球蛋白在阻断乙肝母婴传播中的临床疗效观察丰琳(湖北省黄冈市妇幼保健院检验科,湖北黄冈438000)【摘要】目的探讨分析乙肝疫苗联合免疫球蛋白在乙肝母婴传播途径阻断中的作用效果。方法选取从2010年1月至2012年l1月在我院进行产前检查的住院分娩的200例HBsAg阳性孕妇及脐血为研究对象,所有孕妇的肝功能均正常。按照平均随机抽样的原则平均分为对照组和干预组,各为100例孕妇。对照组的新生儿在出生后24h内接种乙肝疫苗联合免疫球蛋白1.00IU;干预组的孕妇在孕周为28、32和36周时,分别注射200IU的免
2、疫球蛋白各1次,其新生儿在出生后的处理与对照组相同。所有病例均进行成功随访,观察接种后12个月两组新生儿乙肝五项检查情况。结果干预组和对照组的12个月新生儿HBsAg和HBsAb阳性率分别为1%、94%和6%、75%,两组间的差异均有有统计学意义(P3、014)16-0077-02TheCfinicalEffectofHepafitisBVaccineandImmuneGlobuHninInterruptionofHepatitisBTransmissionfromMothertoChildFENGLin(DepartmentofLaboratory,MaternalandChildHealthHospitalofHuanggang,Huanggang438000,China)IAbstract1ObjectiveToexploretheanalysisoftheefectsofhepatitisBvaccinecombin4、edwithimmunoglobulinblockingtherouteoftransmissionofhepatitisBmaternalandchild.MethodsSelectfromJanuary2010toNovemb~2012inourhospitalforprenatalcare,hospitaldeliveryof200HBsAg-positivepregnantwomenandumbilicalcordbloodwereStudies.ALLpmgnantwomenwerenormalliverfunction.Inaccordancewiththepri5、ncipleofrandomsamplingaverageaveragedividedintocontrolandinterventiongroups,eachof100casesofpregnantwomen.Controlgroupofnewbomswithin24hoursafterbirthdoseofhepatitisBvaccinecombinedimmunoglobulin100IU;interventiongroupofpregnantwomeningestationalagewas28,32and36weeks,werecotedimmunoglobulin6、200IUofalltime,theirnewbornsafterbirththesamewiththecontrolgroup.Allcaseswergsuccessfulfollow-up,12months,threegroupsofneonatalhepatitisBfivechecksobservedaftervaccination.ResultsInterventiongroupandthecontrolgroup12monthsnewbornsofHBsAgandHBsAbpositiverateof1%.94%and6%,75%,thediferencebetw7、eenthetwogroupswerestatisticallysignificant
3、014)16-0077-02TheCfinicalEffectofHepafitisBVaccineandImmuneGlobuHninInterruptionofHepatitisBTransmissionfromMothertoChildFENGLin(DepartmentofLaboratory,MaternalandChildHealthHospitalofHuanggang,Huanggang438000,China)IAbstract1ObjectiveToexploretheanalysisoftheefectsofhepatitisBvaccinecombin
4、edwithimmunoglobulinblockingtherouteoftransmissionofhepatitisBmaternalandchild.MethodsSelectfromJanuary2010toNovemb~2012inourhospitalforprenatalcare,hospitaldeliveryof200HBsAg-positivepregnantwomenandumbilicalcordbloodwereStudies.ALLpmgnantwomenwerenormalliverfunction.Inaccordancewiththepri
5、ncipleofrandomsamplingaverageaveragedividedintocontrolandinterventiongroups,eachof100casesofpregnantwomen.Controlgroupofnewbomswithin24hoursafterbirthdoseofhepatitisBvaccinecombinedimmunoglobulin100IU;interventiongroupofpregnantwomeningestationalagewas28,32and36weeks,werecotedimmunoglobulin
6、200IUofalltime,theirnewbornsafterbirththesamewiththecontrolgroup.Allcaseswergsuccessfulfollow-up,12months,threegroupsofneonatalhepatitisBfivechecksobservedaftervaccination.ResultsInterventiongroupandthecontrolgroup12monthsnewbornsofHBsAgandHBsAbpositiverateof1%.94%and6%,75%,thediferencebetw
7、eenthetwogroupswerestatisticallysignificant
此文档下载收益归作者所有